Immune cells in MBL and CLL, although similar phenotypically and transcriptionally, demonstrate an increased number of (predominantly immunosuppressive) cellular interactions vis-a-vis the healthy donors that may be reversed by ibrutinib therapy. Professional illustration by Somersault18:24.